Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Goal-Directed Fluid Therapy Versus Conventional Fluid Therapy for Thoracoscopic Lobectomy in the ERAS Era: A Randomized Controlled Trial

NCT07050979 is registered in ClinicalTrials.gov with Cukurova University as lead sponsor.

NCT NCT07050979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07050979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Goal-Directed Fluid Therapy Versus Conventional Fluid Therapy for Thoracoscopic Lobectomy in the ERAS Era: A Randomized Controlled Trial
Lead sponsor
Cukurova University
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2024
Completion date
January 25, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

enhanced recovery after anesthesia, lung cancer, thoracic anesthesia, thoracoscopic lobectomy